Chairwoman Maloney to Hold Hearing Examining Findings of Committee’s Landmark Drug Pricing Investigation

Dec 3, 2021
Press Release

Washington, D.C. (December 3, 2021)— On Thursday, December 9, 2021, at 10:30 a.m., Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, will hold a hearing to examine the findings from the Committee’s nearly three-year investigation into pharmaceutical pricing and business practices.


On January 14, 2019, the late Chairman Elijah E. Cummings launched the Committee’s historic investigation into the pricing practices of drug companies that sell some of the costliest medications for patients, Medicare, and taxpayers.  Since then, the Committee has released eight staff reports with findings from the Committee’s investigation, including six reports detailing the pricing and business practices of the companies AbbVie Inc., Amgen Inc., Celgene Corporation, Mallinckrodt Pharmaceuticals, Novartis Pharmaceuticals Corporation, and Teva Pharmaceuticals Industries Ltd.   The Committee has also held five hearings with drug company executives, health policy experts, patients, and other stakeholders.


The December 9 hearing will examine findings from the investigation as well as the need for structural reforms to lower prescription drug prices, including President Biden’s Build Back Better Act, which would finally allow Medicare to negotiate for some of the most expensive drugs, prevent drug prices from rising faster than inflation, and place a cap on out-of-pocket costs for patients, including co-pay caps on insulin.




Full Committee hearing entitled, “Unsustainable Drug Prices:  Findings from the Committee’s Drug Pricing Investigation and the Need for Structural Reforms”



Thursday, December 9, 2021, at 10:30 a.m. ET




Mindy Salango

Patient Advocate with Type 1 Diabetes

Morgantown, West Virginia


Dr. Reshma Ramachandran

Physician-Fellow, Yale National Clinician Scholars Program

Co-Chair, Doctors for America Drug Affordability Action Team


Rena Conti, PhD

Associate Professor, Department of Markets, Public Policy, and Law

Questrom School of Business

Boston University


David Mitchell

President and Founder

Patients for Affordable Drugs


Additional Witnesses to be Announced



A livestream will be available on YouTube and the Committee on Oversight and Reform website.  




Per the Office of the Attending Physician’s guidelines, and in consultation with the Architect of the Capitol, the Chief Administrative Officer, the Sergeant at Arms, and the Committee on House Administration, the hearing room has been reconfigured to provide for social distancing.  In light of current guidance from CDC and OAP, media must comply with the Committee’s COVID guidelines, including by continuing to wear masks at all times, regardless of vaccination status.


Seating in the hearing room is extremely limited and as a result, credentialed media must RSVP to their respective Press Gallery no later than 5 p.m. ET on December 8, 2021.  


For more information, please contact the Gallery:   


House Radio/TV Gallery:             202-225-5214

House Periodical Gallery:     202-225-2941

House Daily Press Gallery:   202-225-3945

Photographer Gallery:             202-224-6548



117th Congress